577-11818-92124
3 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 145 / NY
- Registered
- 2021-11-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
WMS-18317-44585
Child or adolescent in my care · Female · 2021-11-11
9Z8-26830-54014
Child or adolescent in my care · Male · 2021-11-13
U72-23267-42322
Child or adolescent in my care · Male · 2022-07-30
Timeline
-
2020-12-23
Dose 1 — Moderna
-
2021-01-20
Dose 2 — Moderna
-
2021-11-09
Dose 3 — Moderna
-
2021-11-11
Registered in v-safe
-
2021-11-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-11-13
- 2021-11-14
- 2021-11-18
- 2021-11-23
- 2021-12-01
- 2021-12-09
- 2021-12-14
- 2021-12-22
- 2022-02-08
-
2022-05-12
Survey response — 6 months, dose 3MedDRA: Fatigue, Paranasal sinus discomfort, Rhinorrhoea — Feeling: GoodFree text: Fatigue + sinus irritation and rubny noseMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Moderna | No |
| 2 | 2021-01-20 | Moderna | No |
| 3 | 2021-11-09 | Moderna | No |
Free text
Release 11 — 6 months, dose 3
Symptoms: Fatigue + sinus irritation and rubny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release